Procter Enterprise Value Over E B I T D A from 2010 to 2024

PG Stock  USD 162.60  1.10  0.68%   
Procter Gamble's Enterprise Value Over EBITDA is increasing over the last several years with slightly volatile swings. Enterprise Value Over EBITDA is predicted to flatten to 10.60. During the period from 2010 to 2024 Procter Gamble Enterprise Value Over EBITDA regressed destribution of quarterly values had coefficient of variationof  18.33 and r-value of  0.56. View All Fundamentals
 
Enterprise Value Over EBITDA  
First Reported
2010-12-31
Previous Quarter
15.91
Current Value
10.6
Quarterly Volatility
2.6442034
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Procter Gamble financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Procter main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.4 B, Interest Expense of 912.9 M or Total Revenue of 58.8 B, as well as many exotic indicators such as Price To Sales Ratio of 4.14, Dividend Yield of 0.0209 or PTB Ratio of 3.8. Procter financial statements analysis is a perfect complement when working with Procter Gamble Valuation or Volatility modules.
  
This module can also supplement Procter Gamble's financial leverage analysis and stock options assessment as well as various Procter Gamble Technical models . Check out the analysis of Procter Gamble Correlation against competitors.
For more detail on how to invest in Procter Stock please use our How to Invest in Procter Gamble guide.

Latest Procter Gamble's Enterprise Value Over E B I T D A Growth Pattern

Below is the plot of the Enterprise Value Over E B I T D A of Procter Gamble over the last few years. It is Procter Gamble's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Procter Gamble's overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Over E B I T D A10 Years Trend
Slightly volatile
   Enterprise Value Over E B I T D A   
       Timeline  

Procter Enterprise Value Over E B I T D A Regression Statistics

Arithmetic Mean14.43
Geometric Mean14.18
Coefficient Of Variation18.33
Mean Deviation2.22
Median15.13
Standard Deviation2.64
Sample Variance6.99
Range8.1735
R-Value0.56
Mean Square Error5.16
R-Squared0.31
Significance0.03
Slope0.33
Total Sum of Squares97.89

Procter Enterprise Value Over E B I T D A History

2024 10.6
2023 15.91
2022 17.67
2021 17.46
2020 17.0
2019 16.36
2018 17.04

About Procter Gamble Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Procter Gamble income statement, its balance sheet, and the statement of cash flows. Procter Gamble investors use historical funamental indicators, such as Procter Gamble's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Although Procter Gamble investors may use each financial statement separately, they are all related. The changes in Procter Gamble's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Procter Gamble's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Procter Gamble Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Procter Gamble. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Enterprise Value Over EBITDA 15.91  10.60 

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Procter Gamble using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Procter Gamble is a strong investment it is important to analyze Procter Gamble's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Procter Gamble's future performance. For an informed investment choice regarding Procter Stock, refer to the following important reports:
Check out the analysis of Procter Gamble Correlation against competitors.
For more detail on how to invest in Procter Stock please use our How to Invest in Procter Gamble guide.
Note that the Procter Gamble information on this page should be used as a complementary analysis to other Procter Gamble's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for Procter Stock analysis

When running Procter Gamble's price analysis, check to measure Procter Gamble's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procter Gamble is operating at the current time. Most of Procter Gamble's value examination focuses on studying past and present price action to predict the probability of Procter Gamble's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procter Gamble's price. Additionally, you may evaluate how the addition of Procter Gamble to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Is Procter Gamble's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Procter Gamble. If investors know Procter will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Procter Gamble listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.106
Dividend Share
3.763
Earnings Share
6.12
Revenue Per Share
35.616
Quarterly Revenue Growth
0.006
The market value of Procter Gamble is measured differently than its book value, which is the value of Procter that is recorded on the company's balance sheet. Investors also form their own opinion of Procter Gamble's value that differs from its market value or its book value, called intrinsic value, which is Procter Gamble's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Procter Gamble's market value can be influenced by many factors that don't directly affect Procter Gamble's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Procter Gamble's value and its price as these two are different measures arrived at by different means. Investors typically determine if Procter Gamble is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Procter Gamble's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.